Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery

NCT00833859 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Abandoned - Lack of funding after only 2 patients enrolled

Conditions

Pancreatic Neoplasms

Interventions

DRUG: GTX (gemcitabine, docetaxel and capecitabine)
RADIATION: stereotactic body radiation therapy

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]